SPC369
Diroxímelfúmarat
Status:
VeittApplication date:
16.3.2022Application published:
15.4.2022Grant published:
15.1.2025
Max expiry date:
19.9.2036Medicine name:
VumerityMedicine for children:
No
Timeline
Today
16.3.2022Application
15.4.2022Publication
15.1.2025Registration
19.9.2036Expires
Marketing license
IS authorization number:
EU/1/21/1585/001-002Date:
1.12.2021
Foreign authorization number:
68066Date:
20.9.2021
Owner
Name:
Alkermes Pharma Ireland LimitedAddress:
Connaught House, 1 Burlington Road, Dublin IE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2970101
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 05.01.2025